SREBF1 and glioblastoma: The significant upregulation of FASN, ANGPTL4, STARD4, and SREBF1 was confirmed in RADH87 primary GBM cells, by 1.9-fold, 1.5-fold, 1.6-fold, and 1.9-fold, respectively (Figure 4B).